Daftar Login

MBS-303 - Drug Targets, Indications, Patents - Synapse - Patsnap

MEREK : mbs303

MBS-303 - Drug Targets, Indications, Patents - Synapse - Patsnap

mbs303MBS303 is a CD20×CD3 T-cell-engaging bispecific antibody that has a novel 2:1 (CD20:CD3) confuration to kill malnant B cells. This dose-escalation phase Ⅰ trialMBS303 OFFICIAL|TEBAK ANGKA 2D 3D

IDR 10.000
IDR 100.000 Disc -90%
Kuantitas